Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 4Phase 1/2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 26Neoplasms 7Liver Neoplasms 7Leukemia, Myeloid, Acute 6Carcinoma, Renal Cell 5Breast Neoplasms 5Recurrence 3Leukemia 3Kidney Neoplasms 3Glioblastoma 3Carcinoma, Non-Small-Cell Lung 3Brain Neoplasms 3Sarcoma 2Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myelodysplastic Syndromes 2Multiple Myeloma 2Melanoma 2Leukemia, Myelomonocytic, Chronic 2Gliosarcoma 2Colorectal Neoplasms 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Stomach Neoplasms 1Sezary Syndrome 1Rectal Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms, Squamous Cell 1Neoplasms, Plasma Cell 1

Interventions

Cetuximab 44Oxaliplatin 39Irinotecan 38Fluorouracil 36Capecitabine 36pembrolizumab 35Leucovorin 35Bevacizumab 35Nivolumab 21Gemcitabine 17regorafenib 13Panitumumab 12IFL protocol 12Folfox protocol 12Cyclophosphamide 12Pemetrexed 11Cisplatin 11tislelizumab 9Paclitaxel 9HMPL-013 9Carboplatin 9130-nm albumin-bound paclitaxel 8durvalumab 7Specimen Handling 7Docetaxel 7trametinib 6Trifluridine 6Ipilimumab 6Drug Therapy 6trifluridine tipiracil drug combination 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Colorectal Neoplasms × Sorafenib × Clear all
NCT00989469 2026-02-05

NEXIRI

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 1/2 Completed
64 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00869570 2019-05-15

External-Beam Radiation Therapy, Capecitabine, and Sorafenib in Treating Patients With Locally Advanced Rectal Cancer

Swiss Cancer Institute

Phase 1/2 Completed
54 enrolled
Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡